埃尔宾通过Ras/Raf途径调节组织因子 凝血障碍 败血症
Cheng Yang1, Chuntian Lei1, Guoqing Jing1
1Research Centre of Anesthesiology and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, 430062, People's Republic of China.
Journal of inflammation research
|February 11, 2025
概括
埃尔宾蛋白通过抑制巨细胞的组织因子释放来调节败血症中的凝血障碍. 这一发现澄清了埃尔宾的情况.
科学领域:
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
背景情况:
- 败血症经常导致凝血障碍.
- 埃尔宾 (ERBB2相互作用蛋白) 与炎症有关.
- 已知巨细胞在败血症引起的凝血中的作用,但埃尔宾的具体参与尚不清楚.
研究的目的:
- 调查Erbin在与败血症相关的凝血障碍中的作用.
- 确定埃尔宾对巨细胞介导凝血的影响.
- 阐明涉及的分子机制.
主要方法:
- 在体外研究:用LPS/PD98059,西部斑点,Co-IP,免疫光,qPCR,组织因子 (TF) 的ELISA对巨细胞进行治疗.
- 在体内研究:小鼠结和穿孔 (CLP) 模型,组织学分析 (HE),免疫组织化学,ELISA,血液凝结试验.
- 统计分析:炎症和凝血指数的皮尔森相关性.
主要成果:
- 在小鼠中,埃尔宾缺失加剧了凝血.
- 巨细胞中的Erbin淘汰会通过Ras/Raf通路激活增加TF分泌.
- 已经证实,Erbin在败血症中调节了巨细胞凝血功能.
结论:
- 埃尔宾抑制了巨细胞释放的TF,从而减少了凝血激活.
- 埃尔宾在败血症引起的凝血障碍中起着保护作用.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Extrinsic and Intrinsic Pathways of Hemostasis
4.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.9K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
Coagulation
4.3K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.3K


